Hendrickson & Long PLLC
General
Cases2
Challenger50%
Patent Owner50%
NPE50%
Practice Areas
Biotech
Top Attorneys
Elite Ratings
DCTPTABCAFC
Analytics
Lawyers
Cases
Ratings Trends
Practice Areas
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 01/14/25 | ORDER GRANTING MOTION TO WITHDRAW AS COUNSEL (ECF NO. 467 ). Attorney Thomas H. Ehrich terminated in case 1:24-md-03103-TSK-JPM and in case 1:22-cv-00061-TSK-JPM. Signed by Chief District Judge Thomas S. Kleeh on 01/14/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM (snc) (Entered: 01/14/2025) | |
| 01/14/25 | MOTION to Withdraw as Attorney - Thomas H Ehrich by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:22-cv-00061-TSK-JPM(Copland, Gordon) (Entered: 01/14/2025) | |
| 04/26/22 | NOTICE of Appearance by Gordon H. Copland on behalf of Kindeva Drug Delivery L.P., Mylan Pharmaceuticals Inc. (Copland, Gordon) (Entered: 04/26/2022) | |
| 04/26/22 | REPORT to USPTO on the filing or determination of an action regarding re 1 Complaint. (kam) (Entered: 04/26/2022) | |
| 04/26/22 | Report on the Filing or Determination of an Action Regarding a Patent or Trademark Other Document filed by AstraZeneca AB, Astrazeneca Pharmaceuticals LP. (Law, Sandra) (Entered: 04/26/2022) | |
| 04/26/22 | Supplemental Information for Patent Cases Involving an Abbreviated New Drug Application (ANDA) Other Document filed by AstraZeneca AB, Astrazeneca Pharmaceuticals LP. (Law, Sandra) (Entered: 04/26/2022) | |
| 04/26/22 | Corporate Disclosure Statement by Astrazeneca Pharmaceuticals LP identifying Corporate Parent AstraZeneca PLC for Astrazeneca Pharmaceuticals LP.. (Law, Sandra) (Entered: 04/26/2022) | |
| 04/26/22 | Corporate Disclosure Statement by AstraZeneca AB identifying Corporate Parent AstraZeneca PLC for AstraZeneca AB.. (Law, Sandra) (Entered: 04/26/2022) | |
| 04/26/22 | Exhibit B Other Document re 1 Complaint filed by AstraZeneca AB, Astrazeneca Pharmaceuticals LP. (Law, Sandra) (Entered: 04/26/2022) | |
| 04/26/22 | COMPLAINT against Kindeva Drug Delivery L.P., Mylan Pharmaceuticals Inc. (Filing Fee $402. Receipt #AWVNDC-3469018), filed by Astrazeneca Pharmaceuticals LP, AstraZeneca AB. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit A) (kam) (Entered: 04/26/2022) |